PT - JOURNAL ARTICLE AU - NG Tolman AU - DG Macalinao AU - AL Kearney AU - KH MacNicoll AU - WN de Vries AU - IJ Jackson AU - SH Cross AU - K Kizhatil AU - KS Nair AU - SWM John TI - Genetic background modifies vulnerability to glaucoma related phenotypes in <em>Lmx1b</em> mutant mice AID - 10.1101/2020.07.05.188516 DP - 2020 Jan 01 TA - bioRxiv PG - 2020.07.05.188516 4099 - http://biorxiv.org/content/early/2020/07/05/2020.07.05.188516.short 4100 - http://biorxiv.org/content/early/2020/07/05/2020.07.05.188516.full AB - Variants in the LIM homeobox transcription factor 1-beta gene (LMX1B)predispose individuals to elevated intraocular pressure (IOP), a key risk factor for glaucoma. However, the effect of LMX1B mutations varies widely between individuals. To better understand mechanisms underlying LMX1B-related phenotypes and individual differences, we backcrossed the Lmx1bV265D allele onto the C57BL/6J (B6), 129/Sj (129), C3A/BLiA-Pde6b+/J (C3H), and DBA/2J-Gpnmb+ (D2-G) strain backgrounds. Strain background had a significant effect on the onset and severity of ocular phenotypes in Lmx1bV265D mutant mice. Mice of the B6 background were the most susceptible to developing elevated IOP, severe anterior segment developmental anomalies (including malformed eccentric pupils, iridocorneal strands, and corneal abnormalities) and glaucomatous nerve damage. In contrast, Lmx1bV265D mice of the 129 background were the most resistant to developing anterior segment abnormalities, had less severe IOP elevation than B6 mutants at young ages, and showed no detectable nerve damage. To identify genetic modifiers of susceptibility to Lmx1bV265D-induced glaucoma-associated phenotypes, we performed a mapping cross between mice of the B6 (susceptible) and 129 (resistant) backgrounds. We identified a modifier locus on Chromosome 18, with the 129 allele(s) substantially lessening severity of ocular phenotypes, as confirmed by congenic analysis. By demonstrating a clear effect of genetic background in modulating Lmx1b-induced phenotypes, by providing a panel of strains with different phenotypic severities and by identifying a modifier locus, this study lays a foundation for better understanding the roles of LMX1B in glaucoma with the goal of developing new treatments.Competing Interest StatementThe authors have declared no competing interest.